Affimed N.V. (NASDAQ:AFMD) Q2 2021 Earnings Conference Call September 8, 2021 8:30 AM ET Company Participants Alex Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Arndt Schottelius - Chief Scientific Officer Wolfgang Fischer - Chief Operating Officer Angus Smith - Chief Financial Officer Conference Call Participants Daina Graybosch - SVB Leerink Maury Raycroft - Jefferies Nick Abbott - Wells Fargo Yale Jen - Laidlaw Operator Good day and wel ...

Affimed N.V. (NASDAQ:AFMD) Q1 2021 Earnings Conference Call July 1, 2021 8:30 AM ET Company Participants Alexander Fudukidis - Head of Investor Relations Adi Hoess - Chief Executive Officer Arndt Schottelius - Chief Scientific Officer Angus Smith - Chief Financial Officer Andreas Harstrick - Chief Medical Officer Denise Mueller - Chief Business Officer Conference Call Participants Maurice Raycroft - Jefferies LLC Daina Graybosch - SVB Leerink LLC Nicholas Abbott - Wells Fargo Securities LLC Yale Jen - Laidl ...

Call Start: 08:30 January 1, 0000 9:30 AM ET Affimed N.V. (NASDAQ:AFMD) Q4 2020 Earnings Conference Call April 15, 2021 08:30 ET Company Participants Alexander Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Angus Smith - Chief Financial Officer Andreas Harstrick - Chief Medical Officer Denise Mueller - Chief Business Officer Conference Call Participants Joseph Kim - Capital Markets Bradley Canino - Credit Suisse Yale Jen - Laidlaw & Co. Daina Graybosch - SVB Leerink Nick Abbott - W ...

Use these links to rapidly review the document TABLE OF CONTENTS Index to consolidated financial statements AFFIMED N.V. (Exact name of Registrant as specified in its charter) Adi Hoess, Chief Executive Officer Tel: (+49) 6221-6743-60 Technologiepark, Im Neuenheimer Feld 582 69120 Heidelberg, Germany (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person) Technologiepark, Im Neuenheimer Feld 582 69120 Heidelberg, Germany, (+49) 6221-6743-60 (Address of principal executive off ...

Affimed N.V. (NASDAQ:AFMD) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Alexander Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Denise Mueller - Chief Business Officer Wolfgang Fischer - Chief Operating Officer Arndt Schottelius - Chief Scientific Officer Angus Smith - Chief Financial Officer Conference Call Participants Tom Kim - BMO Capital Markets Dilip Joseph - SVB Leerink Jim Birchenough - Wells F ...

Affimed N.V. (NASDAQ:AFMD) Q2 2020 Earnings Conference Call August 11, 2020 8:30 AM ET Company Participants Alexander Fudukidis - IR Adi Hoess - CEO Andreas Harstrick - Chief Medical Officer Arndt Schottelius - Chief Scientific Officer Angus Smith - CFO Wolfgang Fischer - COO Denise Mueller - Chief Business Officer Conference Call Participants Maury Raycroft - Jefferies Jim Birchenough - Wells Fargo Ike Oji - BMO Capital Markets Yale Jen - Laidlaw & Company Operator Good day, and welcome to Affimed Second Q ...

Affimed N.V. (NASDAQ:AFMD) Q1 2020 Earnings Conference Call June 23, 2020 8:30 AM ET Company Participants Alexander Fudukidis - Head, Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Arndt Schottelius - Chief Scientific Officer Michael Wolf - Head, Finance Wolfgang Fischer - Chief Operating Officer Conference Call Participants Maury Raycroft - Jefferies James Birchenough - Wells Fargo Yale Jen - Laidlaw & Company Ike Oji - BMO Capital Operator Good day and wel ...

Affimed N.V. (NASDAQ:AFMD) Q4 2019 Earnings Conference Call April 28, 2019 8:30 AM ET Company Participants Greg Gin - Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Michael Wolf - Head of Finance Arndt Schottelius - Chief Scientific Officer Wolfgang Fischer - Chief Operating Officer Denise Mueller - Chief Business Officer Conference Call Participants Jay Birchenough - Wells Fargo I-Eh Jen - Laidlaw & Company Dilip Joseph - SVB Leerink Operator Good day, and ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . OR ☐ SHELL COMPANY REPORT PURSUANT TO S ...